402
Participants
Start Date
September 16, 2013
Primary Completion Date
July 13, 2018
Study Completion Date
July 13, 2018
Triptorelin Acetate 3.75mg intramuscular injection
"Triptorelin Acetate is a Gonadotrophin Releasing Hormone agonist (GnRHa).~Triptorelin acetate for injection 3.75mg administered as described in the patient information sheet approved in China: one intramuscular injection of the product repeated every 4 weeks."
Beijing Anzhen Hospital,Capital Medical University, Beijing
Peking University People's Hospital, Beijing
Beijing Jishuitan Hospital, Beijing
Chinese PLA General Hospital, Beijing
Obstetrics and Gynecology Hospital of Fudan University, Shanghai
The International Peace Maternity & Child Health Hospital of China, Shanghai
Shanghai First Maternity and Infant Hospital, Shanghai
Nanjing Maternity and Child Health Care Hospital, Nanjing
Anhui Provincial Cancer Hospital,Hefei,China,230031, Hefei
Women's Hospital, School of Medicine, Zhejiang University, Hangzhou
Jiangxi Maternal and Child Health Hospital,Nanchang, Nanchang
Xinqiao Hospital,Third Military Medical University, Chongqing
Southwest Hospital,Chongqing,400038, Chongqing
Huazhong University of Science and Technology, Wuhan
Renmin Hospital of Wuhan University (Hubei General Hospital), Wuhan
Henan Provincial People's Hospital, Zhengzhou
Shenzhen People's Hospital, Shenzhen
The Second Hospital of Shanxi Medical University,Taiyuan, Taiyuan
Lead Sponsor
Ipsen
INDUSTRY